Tag: AZD1222
SGS & AstraZeneca sign analytical testing agreement for covid-19 vaccine candidate
SGS announces the signing of an agreement with AstraZeneca for the provision of safety, quality control and analytical testing services in support of AZD1222...
AstraZeneca’s Covid-19 vaccine shows robust responses in Phase I and II...
Interim results from the ongoing Phase I and II COV001 trial, led by Oxford University, showed that AstraZeneca's AZD1222 was tolerated and generated robust...
IQVIA & AstraZeneca team-up to support development of potential Covid-19 vaccine
US- based IQVIA has announced its collaboration with AstraZeneca to accelerate development of a potential new vaccine for Covid-19. This joint initiative is part...
Symbiosis and AstraZeneca sign agreement for sterile manufacture of Covid-19 vaccine
Symbiosis Pharmaceutical Services, a specialist provider of pharmaceutical and vaccine development services, has announced it has signed a supply agreement with AstraZeneca for sterile...